» Articles » PMID: 16933236

Bone Mineral Density Before and After OLT: Long-term Follow-up and Predictive Factors

Overview
Journal Liver Transpl
Date 2006 Aug 26
PMID 16933236
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Fracturing after liver transplantation (OLT) occurs due to the combination of preexisting low bone mineral density (BMD) and early posttransplant bone loss, the risk factors for which are poorly defined. The prevalence and predictive factors for hepatic osteopenia and osteoporosis, posttransplant bone loss, and subsequent bone gain were studied by the long-term posttransplant follow-up of 360 consecutive adult patients with end-stage primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). Only 20% of patients with advanced PBC or PSC have normal bone mass. Risk factors for low spinal BMD are low body mass index, older age, postmenopausal status, muscle wasting, high alkaline phosphatase and low serum albumin. A high rate of spinal bone loss occurred in the first 4 posttransplant months (annual rate of 16%) especially in those with younger age, PSC, higher pretransplant bone density, no inflammatory bowel disease, shorter duration of liver disease, current smoking, and ongoing cholestasis at 4 months. Factors favoring spinal bone gain from 4 to 24 months after transplantation were lower baseline and/or 4-month bone density, premenopausal status, lower cumulative glucocorticoids, no ongoing cholestasis, and higher levels of vitamin D and parathyroid hormone. Bone mass therefore improves most in patients with lowest pretransplant BMD who undergo successful transplantation with normal hepatic function and improved gonadal and nutritional status. Patients transplanted most recently have improved bone mass before OLT, and although bone loss still occurs early after OLT, these patients also have a greater recovery in BMD over the years following OLT.

Citing Articles

Five-year evaluation of bone health in liver transplant patients: developing a risk score for predicting bone fragility progression beyond the first year.

Abate E, McKenna A, Yang L, Ball C, Kearns A Front Endocrinol (Lausanne). 2025; 16:1467825.

PMID: 40052155 PMC: 11882866. DOI: 10.3389/fendo.2025.1467825.


Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations.

Kim K, Ha J, Kim S, Kim J, Lee S, Choi H Endocrinol Metab (Seoul). 2024; 39(2):267-282.

PMID: 38693817 PMC: 11066446. DOI: 10.3803/EnM.2024.1939.


Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation.

Kim D, Yoon Y, Kim B, Choudhury A, Kulkarni A, Park J Hepatol Int. 2024; 18(2):299-383.

PMID: 38416312 DOI: 10.1007/s12072-023-10629-3.


Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX as a Screening Tool.

Sanchez-Delgado J, Profitos J, Arevalo M, Lira A, Marmol C, Miquel M J Clin Med. 2024; 13(1).

PMID: 38202195 PMC: 10780144. DOI: 10.3390/jcm13010188.


Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.

Henson J, King L Clin Liver Dis. 2023; 28(1):193-207.

PMID: 37945160 PMC: 11033708. DOI: 10.1016/j.cld.2023.07.009.